6872 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
NaviFUS Corp. operates as a medical device company. It provides solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. The firm's NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. The company was founded by Hao-Li Liu in 2015 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6872 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company